Canadian Men File Testosterone Lawsuit over Delatestryl
A class action testosterone lawsuit has been filed by men in Canada who claim to have sustained injuries caused by the same hormone-raising treatment, the Sun News Network reports.
According to an article on July 23rd, the case involves Delatestryl, a medication that comes in various forms, including gels, injections, patches and pills. Some of the patients allegedly suffered “an adverse cardiovascular event” that could have been avoided if its manufacturer had properly warned the public about risks associated with the testosterone medication, according to the case. Strokes, heart attacks, deep vein thrombosis, pulmonary embolism and death have been alleged by men involved in this testosterone lawsuit, according to the article, which goes on to mention that these claims have not been proven in court.
FDA Warning Mentions Possible Risks of Delatestryl, other “Low T” Medications
The filing of this testosterone lawsuit is not the first time Delatestryl’s safety has been called into question. On January 31, 2014, the U.S. Food and Drug Administration (FDA) warned that this medication, along with several others, may increase a man’s risk for experiencing serious heart problems. The alert mentioned that side effects may affect patients taking Axiron, AndroGel, Testim and other products designed to raise abnormally-low hormone levels in men, in conjunction with another medical condition. While the association has not been proven, the regulator vowed to investigate the issue further.
Since this alert was issued, a number of testosterone lawsuits have been filed in the U.S., many of which are now pending in the U.S. District Court, Northern District of Illinois. Plaintiffs in these cases similarly allege that manufacturers failed to warn about the risk for cardiovascular side effects, whom they also accuse of promoting their products for low libido, fatigue and other symptoms of aging. According to a Case List updated on July 15th, a total of 156 lawsuits have now been filed in Illinois federal court.
As testosterone lawsuits continue to move forward, the FDA has scheduled a meeting in September to discuss their safety. The meeting will take place on September 17th, and include the regulator’s reproductive and urologic advisory committee and the drug safety and risk management advisory committee.
Pursue a Testosterone Lawsuit
With the safety of testosterone medications currently under scrutiny by the FDA, the time is now to file a lawsuit. Call our Firm today to learn whether you are eligible to file a claim seeking compensation for your injuries: (877) 779-1414.